Immune cell therapy shows promise for tough lupus cases
NCT ID NCT06265220
First seen Dec 17, 2025 · Last updated May 09, 2026 · Updated 16 times
Summary
This early-stage study tests a new treatment called AB-101, made from natural killer cells, combined with antibody therapy for people with lupus nephritis or other hard-to-treat lupus. The goal is to see if it is safe and can help when standard treatments have failed. About 51 adults will receive up to two cycles of the therapy and be monitored for side effects and response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Artiva Investigational Site Aventura
Aventura, Florida, 33180, United States
-
Artiva Investigational Site Birmingham
Birmingham, Alabama, 35249, United States
-
Artiva Investigational Site Charlotte
Charlotte, North Carolina, 28625, United States
-
Artiva Investigational Site Iowa
Iowa City, Iowa, 52242, United States
-
Artiva Investigational Site Mesquite
Mesquite, Texas, 75150, United States
-
Artiva Investigational Site Plantation
Plantation, Florida, 33324, United States
-
Artiva Investigational Site San Diego
San Diego, California, 92121, United States
-
Artiva Investigational Site Tucson
Tucson, Arizona, 85724, United States
-
Artiva Investigational Site Woodlands
The Woodlands, Texas, 77382, United States
Conditions
Explore the condition pages connected to this study.